Media Coverage Related to Conflict-of-Interest

Highlighting NPA’s work on conflicts of interest and commitment to reduce the influence of pharmaceutical marketing on the medical profession

  • “Responding to parts 2-3 of New England Journal of Medicine’s series on pharma-MD relations,” HealthNewsReview.org (5/21/2015)
  • “Criticism of NEJM’s defense of industry-physician relations,” HealthNewsReview.org (5/14/2015)
  • Nothing’s free, in Saturday letters: A light on drugs, doctors,” Houston Chronicle, (8/2/2014) responding to “Federal website to shine light on drug companies, doctors Patients will be able to track manufacturers’ ties to providers,” published 7/27/2014
  • “How Pharma Got Doctors to Prescribe Risperdal, Wellbutrin, Bextra, Neurontin, Prempro and More,” OEN OpEdNews.com (2/17/2014)
  • “Should Doctors Be Barred From Accepting Perks?” Kiplinger (11/2013)
  • “The Influence of Ownership on Human Behavior: ‘Feeding the Beast’” The Medical Professionalism Blog (11/20/2013)
  • “Setting Boundaries: ‘Unbranded Doctor’ Campaign Helps Clarify Potential Conflicts” LeadDoc (10/24/2013)
  • “CarePoint Health Medical Group Physicians: Networking for Better Outcomes and Efficient Practices,” MD News (5/30/2013)
  • “Practicing medicine pharma-free in a drug rep-filled world,” UW Medicine Magazine,  former Past-President David Evans interviewed (5/22/2013)
  • “The Independent Payment Advisory Board and Medicare Spending: New Research Suggests a Change in Our Medical Culture,” Health Beat (5/7/2013)
  • “Consider the source – How academic detailing improves patient care,” Medical College of Wisconsin Alumni Magazine (Spring 2013)
  • “Roche promises greater access to clinical trial data,” PMLiVE (2/27/2013)
  • “Know which pharmaceutical companies are paying your doctor,” Seattle Times (2/16/2013)
  • “What the Sunshine Act Means for Health Care Transparency,” The Atlantic (2/5/2013)
  • “Health Care’s Trick Coin,” New York Times (2/1/2013)
  • “Medical school gift restriction policies and physician prescribing of newly marketed psychotropic medications: difference-in-differences analysis,” BMJ, NPA member Joseph Ross co-author (1/31/2013)
  • “Lobbyists air concerns about doctor gift-disclosure rule at White House,”RegWatch, The Hill’s Regulation Blog (1/29/2013)
  • “Clamor for Sunshine Act Rules Continues,” MedPage Today (1/16/2013)
  • “AARP, AFL-CIO urge OMB to issue Sunshine Act rules,” The Hill Healthwatch Blog (1/15/2013)
  • “The National Physicians Alliance and the American Medical Student Association request full implementation of the sunshine act,” Lexology (1/9/2013)
  • “Groups Urge HHS To Issue Rule on Doctor Payment Disclosure,” iHealthBeat (1/8/2013)
  • “Providers still waiting on Sunshine Act implementation,” FierceHealthCare (1/8/2013)
  • “Groups Urge HHS To Issue Rules On Medical Company-Doc Relationships,” Kaiser Health News (1/7/2013)
  • “Where’s the Physician Sunshine Rule Already?” Politico (1/4/2013)
  • “Groups to HHS: Issue Sunshine Act Rules,” MedPage Today (1/4/2013)
  • “For Bay State ‘modest meals’ are in the eye of the beholder,” Medical Marketing and Media (10/25/2012)
  • “State House News – Patrick mulls gift ban law changes,” State House News Service (7/6/2012)
  • “Disclosure can address doctors’ conflicts of interest,” Philadelphia Inquirer, op-ed by NPA member and director of Pew Prescription Project Daniel Carlat (6/26/2012)
  • “Industry and Academic Medicine: What Does the Future Hold?” UConn Today Blog (6/22/2012)
  • “Dr. Valerie Arkoosh, President of the National Physicians Alliance,” Conversations on Health Care (6/13/2012)
  • “Casting more light on doctors’ financial ties may be delayed,” News Works, NPA member Daniel Carlat quoted (6/1/2012)
  • “Conflicts of Interest in Health Care,” Where We Live, NPA member Stephen Smith interviewed (5/2/2012)
  • “Physicians With Conflicts of Interest,” Health Affairs (4/20120)
  • “Consumers Digest Discovers Pharma Influence over Medicine,” Hooked: Ethics, Medicine, and Pharma (3/23/2012)
  • “Under the Influence: How Doctors are Courted by Drugmakers,” Consumer Digest (March/April 2012)
  • “It’s Enough to Make You Sick,” Consumer Digest (March/April 2012)
  • “What Will End the Era of the Blockbuster Drug?” Time (12/13/2011)
  • “The End of Blockbuster Drugs?” The New Health Dialogue (12/13/2011)
  • “Bipartisan Bill Would Relax FDA Conflicts-of-Interest Policies,” RegBlog (10/20/2011)
  • “Financial Conflicts ‘Pervasive’ On Key Medical Panels,” NPR’s Health Blog (10/12/2011)
  • “Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study,” British Medical Journal (10/11/2011)
  • “Choosing brand-name over generic statins can cost billions,” heartwire (10/3/2011)
  • “Consumer Reports publication quite useful,” Madras Pioneer (9/07/2011)
  • “National Physicians Group Protests FDA Attempts to Allow Industry Influence,” POGO (8/11/2011)
  • “Watchdogs bark as FDA relaxes rules on conflict of interest,” MM&M (8/9/2011)
  • “One practice’s experiment in refusing detail rep visits,” Journal of Family Practice (8/2011)
  • “Data-mining law struck down: Supreme Court sides with drug companies in Vermont ruling,” Modern Healthcare (6/27/2011)
  • “How to Look Good Naked,” Blue Latitude (6/17/2011)
  • “Implementation of the Physician Sunshine Payment Provision: CMS gearing-up to publish notice of proposed rulemaking,” Premier Surgeon (6/13/2011)
  • “When to just say no,” Center for Medical Consumers (6/10/2011)
  • “Doctors Dos and Don’ts,” One Medical Group Blog (6/10/2011)
  • “Under the Influence: Doctors getting big bucks from Big Pharma,” KVNO News (6/2/2011)
  • “Under the Influence – Omaha doctors receive big money from big pharma,” The Reader (6/1/2011)
  • “Why Don’t You Profit When Pharmacies Sell Your Prescription?” Huffington Post (5/20/2011)
    • Cross-posted at Guernica
  • “Limitations Of The Evidence Base For Prescribing Aripiprazole In Maintenance Therapy Of Bipolar Disorder,” Medical News Today (5/3/2011)
  • “Inverse benefits due to drug marketing undermine patient safety and public health,” EurekAlert! (1/13/2011)
    • Reposted at ScienceBlog
  • “The Unbranded Doctor,” Jack’s posterous (1/13/2011)
    • Reposted at PharmaGossip
    • Reposted at Mark Walmsley Blog
  • “New database shows how much drug companies pay doctors,” Philadelphia Inquirer (10/28/2010)
  • “Drug Companies Hire Troubled Doctors As Experts,” NPR (10/19/2010)
  • “Consumer Reports: Most Patients Worry About Pharma Payments to Doctors,” ProPublica (10/18/2010)
  • “Drugmakers hold too much influence over doctors’ decisions, public says,” American Medical News (9/13/2010)
  • “Harvard Medical School Restricts Faculty Ties to Industry,” The Harvard Crimson (7/21/2010)
  • “Avandia Debated LIVE,” AlexO’Meara.com (7/14/2010)
  • “F.D.A. Panel Votes to Restrict Avandia,” New York Times Health Blog (7/14/2010)
  • “N.Y., Minnesota consider new rules on pharma gifts” American Medical News (2/12/2010)
  • “Legislators move to tighten rules for drug companies,” KARE 11, NBC affiliate Minneapolis – St. Paul (1/26/2010)
  • “Groups want tighter controls over drug industry influence,” Minnesota Public Radio (1/26/2010)
  • “Common-sense Rx reforms in Minnesota important to seniors, consumers,” Postscript Blog (1/25/2010)
  • “Lawmakers debate prescription drug reforms,” Session Daily (1/25/2010)
  • “Ethicists Prod NIH to Spend Money Investigating Conflicts of Interest,”The Chronicle of Higher Education (11/17/2009)
  • “UVa posting its doctors’ financial deals online,” Charlottesville Daily Progress (11/12/2009)
  • “An Even Better Picture of Most Influential Doctors in US,” USA Today (10/14/2009)
  • “Service helps health care providers prescribe drugs,” Bangor Daily News (9/21/2009)
  • “A Fierce Fight Over Free Lunches for Physicians,” Hartford Courant (5/25/2009)
  • “Bill Would Limit ‘Gifts’ to Doctors,” ConnPost.Com (4/28/2009)
  • “Doctors increasingly close doors to drug reps,…” American Medical News (3/23/2009)
  • “Attorney General: ban gifts to doctors from drug reps,” Hartford Courant (3/9/2009)
  • “Will biotech change pharma ethics?” ZDNet Healthcare (9/11/08)
  • “Sale of Information to Drug Makers Questioned,” Times-West Virginia (7/30/08)
  • “Lawmakers hear debate on doctor data mining,” Charleston Gazette (7/30/08)
  • “Curbs eyed for Sales of W.VA. Info to Drug Makers,” CNNMoney.com (7/29/08)
  • “Gift Ban Bill Gains Backers,” Boston Globe (6/24/08)
  • “Bill Aims to Cure Costly Side Effects of Doctor Gifts,” Public News Service (5/28/08)
  • “Bill Would Let Pharmacies Sell Medical Records,” San Francisco Chronicle (5/28/08)
  • Letter to Editor re: ghostwriting and gifts to physicians, Baltimore Sun (4/25/08)
  • Letter to Editor re: Gifts to Physicians, New York Times, (4/22/08)
  • Letter to Editor re: MA Senate Gift Ban proposal, Boston Herald, (4/21/08)
  • “Rx ‘Data  Mining’ Legislation Awaits Action in CA, Dies in WA State,” Drug Benefit News (4/04/08)
  • “Physician Gifting Crackdown,” Pharmaceutical Executive (3/26/08)
  • “Bill Makes it Illegal for Drug Makers to buy Prescription Data for Marketing,” Tacoma News Tribune (2/26/08)
  • “Datamining Should get the Shaft,” Seattle Times (2/26/08)
  • “Gathering Data on Docs,” PhillyBurbs.com (1/20/08)
  • “Doctor Combats Pull of Drug Reps” St. Petersburg Times (12/27/07)
  • “Dr. Drug Rep,” NYT Magazine (11/25/07)
  • “Groups Back Physician Gift Disclosure Measure,” Congressional Quarterly HealthBeat (10/23/07)
  • “Putting a Stop to Pharmaceutical Datamining,” op-ed in Lewiston (Maine) Sun Journal (9/30/07)
  • “Improving Health Care or Invading Privacy?” Fosters.com & Laconia (NH) Citizen (9/30/07)
  • “States Move to Close Drug Data Mining,” NPR Marketplace (10/2/07)
  • “Physicians Should Opt-Out,” Bangor Daily News (9/13/07)
  • ReachMD, XM Satellite Radio
  • “Opinion Piece Criticizes Sale of Physician Prescribing Data,” Kaiser Family Foundation (7/26/07)
  • “Drug Industry Mines Physicians’ Data to Boost Sales,” NPR Morning Edition (6/26/07)
  • “Prescription Mining Raises Millions for Doctors’ Group,” San Francisco Chronicle (7/25/07)
  • “AMA Faces Storm on Data Sales,” Chicago Tribune (6/24/07)
  • “Law Targets Drug Marketing Practices” Hudson Valley Business News (6/12/07)
  • “Controversy erupts over pharmaceutical marketing policies,” Dental Tribune
  • FDA Week- coverage regarding New Hampshire ruling on prescription data mining
  • “Doctors, Lawmakers Resist Drugmakers’ Prying Eyes,” Washington Post (5/22/07) A01
  • Editorial voicing the NPA’s support of a bill before the Maine legislature: LD 838, An Act Protecting the Confidentiality of Prescription Information  (4/13/07, Kennebec Journal)
  • “As drug companies push their pills over TV, some are asking: Is that good for your health?” Columbia News Service (4/1/08)
  • Maine Public Radio (3/27/07) interview with NPA Campaign leader Ben Schaefer on the NPA’s support of a prescription privacy bill pending in the Maine legislature
  • “Prescription for Conflict” (3/17/07, Journal News)
  • “No Free Lunch,” Pitt Medicine profile of NPA board member Dave Evans whose practice refuses gifts, visits, and samples from pharmaceutical detailers

Leave a Comment